TrialsgrambetaRCTs are beautiful

RETHINC

2022

Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function

In 535 symptomatic tobacco-exposed adults with preserved spirometry, indacaterol-glycopyrronium for 12 weeks did not improve respiratory symptoms (SGRQ ≥4-point response) compared with placebo.

Result

≥4-point improvement in SGRQ at 12 weeks
Absolute difference
2.6 points

The absolute difference is derived from the event rates.

Original publication
Subtopic
Preserved spirometry
Design
Multicentre RCT
Relevance
Supporting: context rather than must-know.
Source
Han MK, et al. N Engl J Med. 2022;387(13):1173-1184.doi 10.1056/NEJMoa2204752

Discussion & critique

Spirometry is essential before initiating COPD therapy; bronchodilators do not help symptomatic smokers without airflow obstruction.